---
title: "Alloy speeds up timeline for complex fibrosis targets, completing successful antibody discovery collab with Mediar."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/274645487.md"
description: "Alloy Therapeutics Inc., a biotechnology company based in Boston, has recently completed a successful antibody discovery collaboration with Mediar Therapeutics. Through the utilization of Alloy's ATX-Gx™ human transgenic mouse platform, as well as advanced genetic immunization techniques and AI/ML-enabled discovery workflows, Alloy was able to provide a set of unique binders targeting a challenging new target. This collaboration has marked a significant milestone for Alloy, showcasing its commitment to expanding access to cutting-edge drug discovery technologies."
datetime: "2026-02-03T11:08:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274645487.md)
  - [en](https://longbridge.com/en/news/274645487.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274645487.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/274645487.md) | [繁體中文](https://longbridge.com/zh-HK/news/274645487.md)


# Alloy speeds up timeline for complex fibrosis targets, completing successful antibody discovery collab with Mediar.

Alloy Therapeutics Inc., a biotechnology company based in Boston, has recently completed a successful antibody discovery collaboration with Mediar Therapeutics. Through the utilization of Alloy's ATX-Gx™ human transgenic mouse platform, as well as advanced genetic immunization techniques and AI/ML-enabled discovery workflows, Alloy was able to provide a set of unique binders targeting a challenging new target. This collaboration has marked a significant milestone for Alloy, showcasing its commitment to expanding access to cutting-edge drug discovery technologies.

### Related Stocks

- [ProShares Ultra Nasdaq Biotechnology (BIB.US)](https://longbridge.com/en/quote/BIB.US.md)
- [Medicenna Therapeutics Corp. (MDNAF.US)](https://longbridge.com/en/quote/MDNAF.US.md)
- [First Trust NYSE Arca Biotech ETF (FBT.US)](https://longbridge.com/en/quote/FBT.US.md)
- [Vanguard Health Care ETF (VHT.US)](https://longbridge.com/en/quote/VHT.US.md)
- [iShares Global Healthcare ETF (IXJ.US)](https://longbridge.com/en/quote/IXJ.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/en/quote/PBE.US.md)
- [iShares US Pharmaceuticals ETF (IHE.US)](https://longbridge.com/en/quote/IHE.US.md)
- [State Street® SPDR® S&P® Biotech ETF (XBI.US)](https://longbridge.com/en/quote/XBI.US.md)
- [iShares US Medical Devices ETF (IHI.US)](https://longbridge.com/en/quote/IHI.US.md)
- [State Street®HlthCrSelSectSPDR®ETF (XLV.US)](https://longbridge.com/en/quote/XLV.US.md)
- [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/en/quote/IBBQ.US.md)
- [ARK Genomic Revolution ETF (ARKG.US)](https://longbridge.com/en/quote/ARKG.US.md)
- [ALPS Medical Breakthroughs ETF (SBIO.US)](https://longbridge.com/en/quote/SBIO.US.md)
- [Allarity Therapeutics, Inc. (ALLR.US)](https://longbridge.com/en/quote/ALLR.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/en/quote/BBH.US.md)
- [Aligos Therapeutics, Inc. (ALGS.US)](https://longbridge.com/en/quote/ALGS.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/en/quote/IBB.US.md)
- [Allogene Therapeutics, Inc. (ALLO.US)](https://longbridge.com/en/quote/ALLO.US.md)

## Related News & Research

- [bioAffinity Launches Major Lung Cancer Detection Study](https://longbridge.com/en/news/278565253.md)
- [Citius Highlights Positive LYMPHIR Phase 1 Gynecologic Cancer Data](https://longbridge.com/en/news/278566951.md)
- [Galecto Rebrands as Damora Therapeutics with New Ticker](https://longbridge.com/en/news/278556054.md)
- [CSP International Publishes Disclosure on V2D Création Acquisition](https://longbridge.com/en/news/278778570.md)
- [Citius Oncology Reports Positive Phase 1 LYMPHIR Combination Data](https://longbridge.com/en/news/278565911.md)